Bolt

Seyahat & Ulaşım

Incretin Mimetics and Pancreatic Cancer: Evidence and Guidance – Bolt Pharmacy

Do incretin mimetics increase pancreatic cancer risk? Explore the latest evidence, MHRA guidance, and what patients need to know about GLP-1 receptor agonists and pancreatic safety.